After dedicating five years to advocating for individuals with multiple sclerosis (MS), Christina Applegate has disclosed that medical professionals now believe she received an incorrect diagnosis.
Expressing her feelings about the news, she mentioned, “To me, it feels like I’m starting over.” Applegate shared her story during a recent two-part episode of the podcast MeSsy, co-hosted with Jamie-Lynn Sigler, who also has MS. She took a break from the show to cope with this revelation.
During the podcast, Applegate emotionally described her journey, mentioning that while her doctor initially celebrated the absence of MS, she didn’t feel relief but instead felt lost. Despite the misdiagnosis, she noted that her condition has not improved; in some aspects, it has worsened, affecting her mobility.
Multiple sclerosis is a complex autoimmune condition affecting the central nervous system. The disease occurs when the immune system mistakenly attacks the myelin, a protective layer around nerves. This disrupts communication between the brain and body, leading to symptoms like numbness, fatigue, memory problems, mobility issues, and sometimes vision impairment.
Dr. Mark Freedman, a specialist in MS research, likened the damage to a wire’s rubber coating wearing off, leaving the copper inside exposed. This exposure can be targeted by inflammation, leading to nerve damage and permanent disconnection.
Applegate initially revealed her MS diagnosis on social media in August 2021, following months of testing due to symptoms like numbness and pain in her legs. Despite doctors initially suspecting a milder form of MS, further testing revealed numerous lesions on her brain, confirming the diagnosis.
Recent advancements in diagnostic tools prompted a reevaluation of Applegate’s case, leading to the realization that she did not have MS. However, no alternative diagnosis was provided, leaving her uncertain about the cause of her ongoing symptoms.
Feeling like she let others down, Applegate discussed her disappointment on the podcast, expressing her sense of purposelessness without the MS label. Despite this setback, her advocacy efforts remain significant, as acknowledged by her co-host Sigler, who offered support and optimism for the future.
Globally, over 3.1 million individuals live with MS, with Canada having a high prevalence, affecting around 90,000 Canadians, predominantly women. The condition’s diagnosis can be challenging due to overlapping symptoms with other conditions, necessitating accurate testing and evaluation.
Misdiagnosis rates for MS vary worldwide, with studies indicating rates ranging from five to 41 percent. In Applegate’s case, the updated diagnostic criteria and advanced imaging tools played a crucial role in correcting her misdiagnosis.
Continuing her advocacy work despite the misdiagnosis, Applegate’s journey serves as a reminder of the complexities of MS and the importance of accurate diagnosis and treatment to improve patients’ quality of life.